NYtor designs, develops and validates novel molecular diagnostic assays. Our extensive expertise in multiplex qPCR (real-time PCR) development ensures design of robust and sensitive assays for application in e.g. gene expression, genotyping and detection of pathogens.
Tailor-made applications and approaches are an important aspect of our service. NYtor is a reliable business partner, focusing on long-term relationships based on personal interactions.
NYtor is currently in transition phase towards obtaining ISO 13485 certification.